Lamotrigine in dried blood spots by HPLC

Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde

Volumn 31, Issue 3, 2006, Pages 238-239

  Soons, J W P H ^a   Van Bree, M L ^a   Coumou, J H ^a   Hulsman, J A R J ^a  

^a Epilepsy Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN;

EID: 33746875979     PISSN: 15708306     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Brodie MJ, Richens A, Yuen AWC. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995; 345: 476-479.
2. Steiner TJ, Silveira C, Yuen AWC, et al. Comparison of lamotrigine (Lamictal) and phenytoin monotherapy in newly diagnosed epilepsy. Epilepsia 1994; 35 Suppl. 7: 61.
3. Fitton A, Goa KL. Lamotrigine, an update of its pharmacology and therapeutic use in epilepsy. Drugs 1995; 50: 691-713.
4. Zytkovicz TH, Fitzgerald EF, Marsden D, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 2001; 47: 1945-1955.
5. Vollmer DW, Jinks DC, Guthrie R. Isocratic reverse-phase liquid chromatography assay for amino acid metabolic disorders using eluates of dried blood spots. Anal Biochem 1990; 189: 115-121.